Hospital Universitario Marqués de Valdecilla -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2020

  1. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

    Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268

2011

  1. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): Results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005

    British Journal of Haematology, Vol. 154, Núm. 5, pp. 600-611

2009

  1. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: A Report from the spanish working party for blood and marrow transplantation in children (GETMON)

    Pediatric Hematology and Oncology, Vol. 26, Núm. 5, pp. 345-355

2008

  1. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission - Similar outcomes after matched related and unrelated donor transplant: A study of the Spanish working party for blood and marrow transplantation in children (Getmon)

    Pediatric Hematology and Oncology, Vol. 25, Núm. 4, pp. 245-259

2005

  1. Erratum: Resultados terapéuticos en la leucemia linfoblástica aguda infantil con los protocolos SHOP de la Sociedad Española de Hematología Pediátrica (SEHP) y la Sociedad Española de Oncología Pediátrica (SEOP). 1989-2005 (Revista Espanola de Pediatria (2005) 61, 4 (273))

    Revista Espanola de Pediatria

  2. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998

    Bone Marrow Transplantation, Vol. 35, Núm. 9, pp. 895-901

2000

  1. Autologous stem cell transplantation for advanced Hodgkin's disease in children

    Bone Marrow Transplantation, Vol. 25, Núm. 1, pp. 31-34